NeuroSense Therapeutics Current Cash

NeuroSense Therapeutics (NRSN) currently reports a current cash of $170K as of December 2025. That compares with $3.4M in the prior-year period — down 95.1% year over year. Use the charts on this page to explore NeuroSense Therapeutics's current cash history and peer comparisons.

NeuroSense Therapeutics's current cash decreased from $3.4M to $170K — a 95.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics reported $170K in current cash as of December 2025. That compares with $3.4M in the prior-year period — down 95.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics, and consider following NRSN for alerts when major investors trade the stock.